Histone H2B ubiquitin ligase RNF20 is required for MLL -rearranged leukemia
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Mixed-lineage leukemia (MLL) fusions are potent oncogenes that initiate aggressive forms of acute leukemia. As aberrant transcriptional regulators, MLL-fusion proteins alter gene expression in hematopoietic cells through interactions with the histone H3 lysine 79 (H3K79) methyltransferase DOT1L. Notably, interference with MLL-fusion cofactors like DOT1L is an emerging therapeutic strategy in this disease. Here, we identify the histone H2B E3 ubiquitin ligase ring finger protein 20 (RNF20) as an additional chromatin regulator that is necessary for MLL-fusion-mediated leukemogenesis. Suppressing the expression of Rnf20 in diverse models of MLL-rearranged leukemia leads to inhibition of cell proliferation, under tissue culture conditions as well as in vivo. Rnf20 knockdown leads to reduced expression of MLL-fusion target genes, effects resembling Dot1l inhibition. Using ChIP-seq, we found that H2B ubiquitination is enriched in the body of MLL-fusion target genes, correlating with sites of H3K79 methylation and transcription elongation. Furthermore, Rnf20 is required to maintain local levels of H3K79 methylation by Dot1l at Hoxa9 and Meis1. These findings support a model whereby cotranscriptional recruitment of Rnf20 at MLL-fusion target genes leads to amplification of Dot1l-mediated H3K79 methylation, thereby rendering leukemia cells dependent on Rnf20 to maintain their oncogenic transcriptional program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, H2B monoubiquitylation induced by the ubiquitin ligase RNF20 was necessary for leukemic cell growth in MLL-AF9 leukemia.47”
From USP22 deficiency leads to myeloid leukemia upon oncogenic Kras activation through a PU.1-dependent mechanism (2018) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 1×
“Using gene set enrichment analysis (GSEA), we further verified a systematic suppression of MLL-AF9 target gene expression upon Rnf20 knockdown (35).”
MethodIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 1×
“Targeting of other E3 ligase proteins with known drugs provides proof-ofprinciple that potent small-molecule inhibitors can be developed against this class of enzymes (46, 47).”
BackgroundFunctional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs
Rinn, J. L., Kertesz, M., Wang, J. K., Squazzo, S. L., Xu, X., Brugmann, S. A., Goodnough, L. H., Helms, J. A., Farnham, P. J., Segal, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.022 · Cited by 4,244
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991 · cited 1×
“Heat maps were generated with Java Tree View using a 20 reads per million per kilobase (RPKM) expression cutoff (49).”
MethodIdentification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136 · cited 1×
“Targeting of other E3 ligase proteins with known drugs provides proof-ofprinciple that potent small-molecule inhibitors can be developed against this class of enzymes (46, 47).”
BackgroundRNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870 · cited 12×
“Furthermore, RNF20 knockdown inhibited the proliferation of human AML lines harboring MLL translocations (MOLM-13, MV4-11, and THP-1), whereas the non–MLL-rearranged AML line CMK was affected to a lesser extent (Fig.”
BackgroundSelf-citationPrinciples of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765 · cited 1×
“As a result, leukemia cells rely on RNF20 to maintain their leukemogenic gene expression program in a form of “nononcogene addiction” (42).”
BackgroundGenomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse
Bernstein, B. E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D. K., Huebert, D. J., McMahon, S., Karlsson, E. K., Kulbokas, E. J., Gingeras, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.001 · Cited by 1,527 · cited 1×
“It is interesting to note that the HOXA cluster possesses a unique chromatin architecture: a dense arrangement of genes in identical orientation, broad domains of histone modifications (43), extensive higher order chromatin interactions (44), and several interspersed long noncoding RNAs (45).”
BackgroundMLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249 · cited 17×
“Furthermore, RNF20 knockdown inhibited the proliferation of human AML lines harboring MLL translocations (MOLM-13, MV4-11, and THP-1), whereas the non–MLL-rearranged AML line CMK was affected to a lesser extent (Fig.”
BackgroundInfluentialShilatifard, A. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051710-134100 · Cited by 1,091
Cited by
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
Shi, J., Wang, E., Milazzo, J. P., Wang, Z., Kinney, J. B., & Vakoc, C. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3235 · Cited by 761
Self-citationBorn to run: control of transcription elongation by RNA polymerase II
Chen, F. X., Smith, E. R., & Shilatifard, A. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0010-5 · Cited by 447
MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
Winters, A. C., & Bernt, K. M. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00004 · Cited by 405
“H2Bub is required for the methylation of H3K79 mono- to di- and trimethylation (166), and knockdown of the H2B ubiquitin ligase RNF20 led to decrease in H3K79me2 mark at MLL target gene sites and in vitro and in vivo compromise of leukemia cell viability (167).”
BackgroundRoe, J.-S., Mercan, F., Rivera, K., Pappin, D. J., & Vakoc, C. R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.04.011 · Cited by 337
“It has been previously proposed that BET inhibitors directly displace the MLL-fusion oncoprotein from chromatin; however, this model is contradicted by a lack of effect for BET inhibition on the expression of primary MLL-fusion target genes at the HOXA cluster (Dawson et al., 2011, 2014; Wang et al., 2013).”
BackgroundMethodSelf-citationMechanism of Cross-talk between H2B Ubiquitination and H3 Methylation by Dot1L
Worden, E. J., Hoffmann, N. A., Hicks, C. W., & Wolberger, C. (2019) · Cell · doi:10.1016/j.cell.2019.02.002 · Cited by 236
“Knockdown of human RNF20 or RNF40, which form the RNF20/40 heterodimeric E3 ligase that ubiquitinates H2BK120, leads to a decrease in H3K79 methylation in human cells (Wang et al., 2013; Zhu et al., 2005).”
Background
Metadata
- Authors
- Wang, E., Kawaoka, S., Yu, M., Shi, J., Ni, T., Yang, W., Zhu, J., Roeder, R. G., & Vakoc, C. R.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Rockefeller University (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-02-14
- Volume
- 110
- Issue
- 10
- Pages
- 3901-3906
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3593849
- OpenAlex
- W2014880942
- Cited by
- 121
- References
- 50
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 15 · 2020: 11 · 2019: 9 · 2018: 12 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 4
- FWCI
- 6.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- F. M. Kirby Foundation
- Leukemia and Lymphoma Society
- Edward P. Evans Foundation
- James N. Kirby Foundation
- National Institutes of Health (5p30ca045508-35)
- National Cancer Institute (P30-CA045508, CA45508)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- RNF20, MLL rearrangement, MLL fusion proteins, DOT1L, H3K79 methylation, histone H2B ubiquitination, E3 ubiquitin ligase, acute leukemia, transcriptional regulation, HOXA9, MEIS1, transcription elongation, leukemogenesis, chromatin regulation
- MeSH terms
- Animals, Base Sequence, DNA, Neoplasm, Histones, Humans, Models, Biological, Molecular Sequence Data, Histone-Lysine N-Methyltransferase, Proto-Oncogenes, Gene Rearrangement, Leukemia, Myeloid, Acute, Oncogene Proteins, Fusion, RNA, Small Interfering, Ubiquitin-Protein Ligases, Cell Line, Tumor, Mice, Myeloid-Lymphoid Leukemia Protein, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histone H2B ubiquitin ligase RNF20 is required for MLL -rearranged leukemia. https://app.cochat.ai/papers/10.1073/pnas.1301045110
- The paper
- Wang, E., Kawaoka, S., Yu, M., Shi, J., Ni, T., Yang, W., Zhu, J., Roeder, R. G., & Vakoc, C. R. (2013). Histone H2B ubiquitin ligase RNF20 is required for MLL -rearranged leukemia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1301045110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.